BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 1918913)

  • 1. Urine drug screens.
    Cockrell K
    Indiana Med; 1991 Jun; 84(6):416-7. PubMed ID: 1918913
    [No Abstract]   [Full Text] [Related]  

  • 2. Interferences with urine drug screens.
    Herring C; Muzyk AJ; Johnston C
    J Pharm Pract; 2011 Feb; 24(1):102-8. PubMed ID: 21507878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Urine testing in the treatment of opiate addiction].
    Ege PP
    Ugeskr Laeger; 2003 Mar; 165(13):1346-8. PubMed ID: 12703279
    [No Abstract]   [Full Text] [Related]  

  • 4. [Adulteration of urine drug testing--an exaggerated cause of concern].
    Beck O; Bohlin M; Bragd F; Bragd J; Greitz O
    Lakartidningen; 2000 Feb; 97(7):703-6. PubMed ID: 10740378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A tale of two drug testing technologies: GC-MS and LC-MS/MS.
    Mikel C; Pesce A; West C
    Pain Physician; 2010; 13(1):91-2. PubMed ID: 20119467
    [No Abstract]   [Full Text] [Related]  

  • 6. Importance of urine drug testing in the treatment of chronic noncancer pain: implications of recent medicare policy changes in kentucky.
    Gilbert JW; Wheeler GR; Mick GE; Storey BB; Herder SL; Richardson GB; Watts E; Gyarteng-Dakwa K; Marino BS; Kenney CM; Siddiqi M; Broughton PG
    Pain Physician; 2010; 13(2):167-86. PubMed ID: 20309383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is quantitative urinalysis more sensitive?
    Li SH; Chiang N; Tai B; Marschke CK; Hawks RL
    NIDA Res Monogr; 1997; 175():265-86. PubMed ID: 9467804
    [No Abstract]   [Full Text] [Related]  

  • 8. Evaluation of thin-layer chromatography methods for laxative detection.
    Duncan A; Phillips IJ
    Ann Clin Biochem; 2001 Jan; 38(Pt 1):64-6. PubMed ID: 11270846
    [No Abstract]   [Full Text] [Related]  

  • 9. Detection of drug abuse by health professionals.
    Meeker JE; Mount AM; Ross W
    Occup Health Saf; 2002 Aug; 71(8):46-50. PubMed ID: 12197441
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparison of reported drug use and urinalysis in the assessment of drug use.
    Jain R; Tripathi BM; Singh R
    Natl Med J India; 2001; 14(5):315-6. PubMed ID: 11767230
    [No Abstract]   [Full Text] [Related]  

  • 11. [On-site testing for drug abuse in urine].
    Espnes KA; Spigset O; Delaveris GJ; Mørland J; Smith-Kielland A
    Tidsskr Nor Laegeforen; 2006 Sep; 126(17):2257-60. PubMed ID: 16967064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Uniform analyzes of drugs in urine needed for rule of law].
    Hansson T; Helander A; Beck O; Elmgren A; Kugelberg F; Kronstrand R
    Lakartidningen; 2015 Sep; 112():. PubMed ID: 26393972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Interpretation of Urine Drug Tests: What Clinicians Need to Know About Urine Drug Screens.
    Moeller KE; Kissack JC; Atayee RS; Lee KC
    Mayo Clin Proc; 2017 May; 92(5):774-796. PubMed ID: 28325505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A procedure for the detection of Stealth adulterant in urine samples.
    Valtier S; Cody JT
    Clin Lab Sci; 2002; 15(2):111-5. PubMed ID: 12776774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adulterants in Urine Drug Testing.
    Fu S
    Adv Clin Chem; 2016; 76():123-63. PubMed ID: 27645818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of quantitative urinalysis in monitoring cocaine use.
    Preston KL; Silverman K; Schuster CR; Cone EJ
    NIDA Res Monogr; 1997; 175():253-64. PubMed ID: 9467803
    [No Abstract]   [Full Text] [Related]  

  • 17. A comparison of ONTRAK TESTCUP, abuscreen ONTRAK, abuscreen ONLINE, and GC/MS urinalysis test results.
    Crouch DJ; Cheever ML; Andrenyak DM; Kuntz DJ; Loughmiller DL
    J Forensic Sci; 1998 Jan; 43(1):35-40. PubMed ID: 9456522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of fluid load on human urine characteristics related to workplace drug testing.
    Chaturvedi AK; Sershon JL; Craft KJ; Cardona PS; Soper JW; Canfield DV; Dubowski KM; Whinnery JE; Leyva MJ; Aston CE; Blevins SM; Wright JE; Fraser AD; Kuntz DJ
    J Anal Toxicol; 2013; 37(1):5-10. PubMed ID: 23104711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Summary of a blind quality assurance program for urinalysis.
    Dyszel SM; Erikson CM; Hood LV
    J Anal Toxicol; 1993; 17(3):190-1. PubMed ID: 8336496
    [No Abstract]   [Full Text] [Related]  

  • 20. Implementing a mandatory drug screening program: pros and cons for the dialysis unit.
    Bednar B; Peacock E
    Nephrol News Issues; 1993 Jan; 7(1):14-5. PubMed ID: 8479549
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.